Edition:
United States

Ucb SA (UCB.BR)

UCB.BR on Brussels Stock Exchange

72.14EUR
11:35am EDT
Change (% chg)

€0.16 (+0.22%)
Prev Close
€71.98
Open
€72.00
Day's High
€72.68
Day's Low
€71.82
Volume
358,831
Avg. Vol
332,324
52-wk High
€81.48
52-wk Low
€65.42

About

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia,... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €11,689.79
Shares Outstanding(Mil.): 194.51
Dividend: 1.15
Yield (%): 1.34

Financials

  UCB.BR Industry Sector
P/E (TTM): 17.05 29.30 32.55
EPS (TTM): 3.53 -- --
ROI: 8.89 14.23 13.82
ROE: 12.31 15.46 15.24

Earnings vs. Estimates